ArticleESMO open2018
Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy.
Christopher Nevala-Plagemann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it